Lecture 7- Special populations Flashcards

1
Q

Special populations

A

Drugs don’t work the same in every person

People respond in different ways

  • disease
  • pregnancy
  • age
  • sex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Most of our understanding of special populations comes from

A

Pharmacokinetics

  • how the body changes the drug
  • changes in ADME

We know very little about changes due to pharmacodynamics

  • drug response caused by drug-receptor interactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Disease: special populations

A
  • Many diseases alter drug exposure and response
  • Most disease is the result of Hepatic (liver) and renal (kidney) impairment
  • Effect of hepatic and renal impairments on pharmacokinetics are multifactorial
  1. Organ size
  2. Tissue composition
  3. Blood flow
  4. Enzyme activities
  5. Transport activities
  6. Protein binding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Chronic kidney disease

A
  • Kidney effectiveness= GFR
  • how well they are filtering per min
  • Using GFR as a metric -> putting people into different classes of kidney failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ganciclovir

A
  • anti-viral used to treat cytomegalovirus (CMV)
  • eliminated primarily through kidney excretion
  • creatine clearance is used as a proxy for GFR
  • *renal impairment can slow drug elimination*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Example of ACE inhibitors being renoprotective

A
  • ACE inhibitors is renoprotective in diabetes
  • ACE inhibitors lower bp
  • in diabetes, there is higher afferent flow
  • leads to higher pressure in glomerulus
  • ACE inhibitors block Ang 2, leads to dilation of efferent
  • balances out the pressure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Example of ACE inhibitors in renal failure

A
  • Renal failure: have reduce afferent flow
  • opening it up even more, having no pressure coming through capillaries
  • kidneys lose ability to filter
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Relationship between Hepatic impairment and metabolism

A
  • the amount of drug removed by the liver is dependent on hepatic blood flow
  • Hepatic impairment -> decreased blood flow -> decreased metabolism
  • As hepatic function decreases, all the different CYP enzymes decrease at different rates
  • some drugs metabolized by diff CYPs,
  • Do get decreased drug metabolism with impairment of the liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Liver impairement and oral drug bio-availability

A
  • The magnitude of change in drug exposure due to the effect of hepatic impairment on oral bioavailability depends on the extent of hepatic extraction
  • Some drugs are metabolized more by the liver by first pass than others
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cirrhosis

A
  • complication of liver disease
  • commonly caused by:
  1. long term alcohol abuse
  2. viral hepatitis B and C
  • loss of liver cells and permanent scarring
  • liver function greatly decreased
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Chlormethiazole

A
  • has a high hepatic extraction ratio
  • used to treat and prevent symptoms of acute alcohol withdrawal
  • alcohol use can lead to overdose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pregnancy

A

profound physiological change

  • increased GFR
  • altered hepatic metabolism
  • GI motility slows
  • changes in drug volume of distribution
  • many other changes: respiratory rate, bp, plasma albumin, heat rate, etc

All of these changes affect pharmacokinetics

ex: amocillin concentrations are lower during pregnancy than post-partum
* due to increased GFR

Many drugs can pass through the placental barrier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

teratogenic

A
  • agent that can disturb the development of an embryo or fetus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

FDA safety categories

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tetracycline

A
  • teratogenic antibiotic
  • causes permanent discoloration of teeth in infants and children when used during pregnancy
17
Q

Thalidomide

A
  • sedative used for morning sickness in the 50’s
  • caused severe birth defects
18
Q

Male and female differences

A
  • males weigh more, yet many drugs dosing is not corrected for body weight
  • body fat: females > males
  • GFR: females < males
  • differences in drug metabolizing enzyme activities: some CYPs are more active in males/females
19
Q

Midazolam

A
  • AKA Versed
  • used for procedural sedation or trouble sleeping
  • cleared primarily by CYP3A4
  • given orally -> first pass metabolism-> do see a mean difference between women and men of serum concentrations , higher clear in women
20
Q

Sex dependent differences in pharmacodynamics

A

Long QT syndrome

  • no signs or symptoms
  • can lead to fainting, seizures, and sudden death
  • women have a higher risk of drug-induced Long QT syndrome
  • are thought to be due to females having longer baseline QT interval and a difference in the abundance of potassium cardiac channels
21
Q

Drug differences with children (distribution)

A
  • children have a higher distribution of extracellular body water than adults
  • results in hydrophilic drugs distributing more
  • differences in body fat affect hydrophobic drug distribution
  • children have a lower proportion of proteins –> decreased protein binding –> changes distribution
22
Q

Drug differences with children (renal elimination)

A
  • renal elimination changes during development
  • decreased in newborns
  • increased in children
  • Kidney function in infants: GFR decreased compared to an adult
  • Kids can clear drugs faster than adults, may receive a higher dose
23
Q

Drug differences with children (hepatic elimination)

A
  • CYP and glucuronidation activity take time to develop
  • slower elimination rates and increased half-life in newborns
  • toddlers tend to have a higher metabolic activity than adults
  • Decreased hepatic elimination early in life
  • Don’t see normal CYP3A4 activity until later on
24
Q

Gray baby syndrome

A
  • an adverse event occurring in newborn infants following I.V administration of the antimicrobial, chloramphenicol
  • drug not usually used in newborns or premature babies

Caused by:

  1. reduced glucuronidation of chloramphenicol
  2. reduced renal elimination of chloramphenicol
25
Q

Reye’s syndrome

A
  • rare adverse event occurring associated with giving aspirin to children who have viral infections (flu, chickenpox, respiratory infections)
  • causes swelling in the liver and brain
  • cause = unknown
  • DON’T USE ASPIRIN IN BABIES
26
Q

Considerations for geriatrics

A
  • reduction in hepatic mass and blood flow
  • changes in plasma protein composition
  • reduction in renal mass and GFR
  • Increased body fat -> hydrophobic drugs better distributed